Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

World-Renowned Physician Dr. David Agus Joins CrossChx Board of Directors

Posted on: 12 Oct 16

PR Newswire

COLUMBUS, Ohio, Oct. 12, 2016

COLUMBUS, Ohio, Oct. 12, 2016 /PRNewswire/ -- CrossChx, the company giving people a better way to connect and share information about their health, announced today the addition of accomplished biomedical researcher, world renowned oncologist and entrepreneur, Dr. David Agus, to its board of directors. Effective immediately, Dr. Agus, also a New York Times bestselling author, will serve as a key adviser to the company's executive team and contribute to the long-term goal of using technology to extend life expectancy.

"Dr. Agus is well regarded for his ability to take conventional wisdom and turn it on its head, so naturally we felt he would fit in well at CrossChx," said Sean Lane, CEO and Co-Founder of CrossChx. "His experience and knowledge will help us continue to build better ways for people to connect and share their health information. We share a supercharged focus on making people healthier by strengthening and enriching the relationships between patients, payers, and providers."

Dr. Agus is a professor of medicine and engineering at the University of Southern California (USC) Keck School of Medicine and Viterbi School of Engineering and the CEO and founding director of USC's Lawrence J. Ellison Institute for Transformative Medicine. He is one of the world's leading physicians specializing in treating patients with advanced forms of cancer, is the co-founder of several personalized medicine companies and has served in leadership roles at the World Economic Forum.

"This company's hard work and determination to completely rethink and retool the way patients connect to their health immediately caught my attention and their growth is remarkable," said Dr. Agus. "The work CrossChx is doing will forever change the way we experience healthcare and interact with our health information. I'm excited to be part of the team."

Well regarded for his innovations in medicine, Dr. Agus has built a reputation for taking a unique approach to looking at the relationship of the human body to health and disease. Over the years he has treated a number of high-profile patients, including Apple Co-Founder Steve Jobs, musician Neil Young and former U.S. Senator Ted Kennedy among many others. He appears on television regularly as a medical contributor for CBS News.

"The End of Illness," Dr. Agus' first book published in 2012, is a New York Times #1 and international bestseller and was the subject of a television series on PBS. His most recent books "A Short Guide to a Long Life" and "The Lucky Years: How to Thrive in the Brave New World of Health" are also New York Times and international bestsellers.

Dr. Agus holds degrees from Princeton University and the University of Pennsylvania School of Medicine, and currently lives in California with his wife and two children.

About CrossChx 
CrossChx is building an identity layer for healthcare that gives patients and providers a better way to connect to health. The company's flagship platform, Connect, offers secure, intuitive and data-rich features including biometric verification and mobile information management to patients, practices, hospitals and care managers. Headquartered in Columbus, Ohio, CrossChx has signed more than 350 health systems nationwide and created more than 60 million unique patient IDs for healthcare. For more information, visit

Press Contacts:

Josh Chaney 

Logo -


To view the original version on PR Newswire, visit:


PR Newswire

Last updated on: 12/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.